abstract |
(57) [Summary]nThe present invention relates to the field of clinical pharmacology and is based on an injection administered as a targeting drug, comprising a combination of a glucocorticoid and an anti-inflammatory analgesic. This injection shows an effective and long-lasting effect on musculoskeletal soft tissue disorders very quickly and has no side effects. |